DWM
KYMR icon

Drive Wealth Management’s Kymera Therapeutics KYMR Stock Holding History

Drive Wealth Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
2,773
-105
-4% -$9.02K 0.06% 294
2026
Q1 		$240K Buy
2,878
+81
+3% +$6.41K 0.05% 303
2025
Q4 		$218K Buy
+2,797
New +$189K 0.04% 343

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Drive Wealth Management's KYMR Position: Q2 2026 in Review

Drive Wealth Management reduced its Kymera Therapeutics (KYMR) stake by 3.6% in Q2 2026, selling an estimated $9.02K and leaving 2,773 shares worth $318K. The position accounts for 0.06% of the portfolio, ranked #294.

Drive Wealth Management first reported a position in KYMR in Q4 2025 and has held it in 3 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Drive Wealth Management held 2,773 shares of Kymera Therapeutics worth $318K as of Q2 2026.
  • Drive Wealth Management sold 105 Kymera Therapeutics shares in Q2 2026, an estimated $9.02K.
  • Kymera Therapeutics made up 0.06% of Drive Wealth Management's portfolio in Q2 2026, its #294 holding.
  • Drive Wealth Management first reported a position in Kymera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.